Lexicon Pharmaceuticals, Inc. (LXRX) Financials

LXRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 276.5 million 137.0 million
2023-06-30 316.7 million 130.4 million
2023-03-31 162.7 million 74.7 million
2022-12-31 194.3 million 77.2 million

LXRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -41.7 million 3.9 million
2023-06-30 -38.3 million 3.8 million
2023-03-31 -31.9 million 3.4 million
2022-12-31 -22.8 million 3.3 million

LXRX Net Income

No data available :(

LXRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 218.4 million - 6.7 million
2023-06-30 256.7 million - 6.8 million
2023-03-31 105.9 million 48.8 million 6.7 million
2022-12-31 138.4 million - 6.7 million

LXRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 244.9 million
2023-06-30 204.8 million
2023-03-31 189.0 million
2022-12-31 188.7 million

LXRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 83000 17.6 million 2.6 million 29.7 million
2023-06-30 139000 14.5 million 30.0 million 27.5 million
2023-03-31 248000 12.0 million 2.2 million 16.9 million
2022-12-31 1.2 million 14.0 million 10.7 million 5.6 million

LXRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 162000 7000
2023-06-30 317000 8000
2023-03-31 24000 112000
2022-12-31 28000 103000

LXRX

Price: $1.58

52 week price:
0.92
3.79

Earnings Per Share: -0.80 USD

P/E Ratio: -4.38

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 131023

Ebitda: -28.2 million

Market Capitalization: 460.5 million

Links: